Rhythm Pharmaceuticals' Grant

Rhythm Pharmaceuticals raised a round of funding on September 11, 2013. Investors include The Michael J. Fox Foundation.

Rhythm Pharmaceuticals is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm is developing the ghrelin peptide agonist, RM-131, for the trea…

Articles about Rhythm Pharmaceuticals' Grant: